141P Circulating immune cells predict immunotherapy benefit in patients with triple negative breast cancer: Preliminary results from the IRIS study. - Conte, B.; Martini, V.; Alsati, R.; Boldorini, R.; Gobbato, S.; Negrini, L.; Ben Ayed, R.; Ruffilli, B.; Vezzoli, F.; Sala, N.; Matera, L.; Branni, C.; et al. (Annals of Oncology, 2024)